He Shan-Jin

Beijing Key Laboratory Of Early Prediction And Intervention Of Acute Myocardial Infarction
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Letter by Jin-shan and Xue-bin Regarding Article, "Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality".

Letter by Jin-shan and Xue-bin Regarding Article, "Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality".

Journal: Circulation
Published: May 08, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"

Letter by Jin-shan and Xue-bin Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"

Journal: Circulation
Published: May 02, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Platelets Express Activated P2Y12 Receptor in Patients With Diabetes Mellitus".

Letter by Jin-shan and Xue-bin Regarding Article, "Platelets Express Activated P2Y12 Receptor in Patients With Diabetes Mellitus".

Journal: Circulation
Published: April 25, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis".

Letter by Jin-shan and Xue-bin Regarding Article, "Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis".

Journal: Circulation
Published: April 18, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"

Letter by Jin-shan and Xue-bin Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"

Journal: Circulation
Published: April 11, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?"

Letter by Jin-shan and Xue-bin Regarding Article, "Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?"

Journal: Circulation
Published: April 04, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis".

Letter by Jin-shan and Xue-bin Regarding Article, "Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis".

Journal: Circulation
Published: March 28, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".

Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".

Journal: Circulation
Published: March 21, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".

Letter by Jin-shan and Xue-bin Regarding Article, "A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".

Journal: Circulation
Published: March 14, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study".

Letter by Jin-shan and Xue-bin Regarding Article, "Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study".

Journal: Circulation
Published: March 07, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".

Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".

Journal: Circulation
Published: February 28, 2018

Letter by Jin-shan and Xue-bin Regarding Article, "Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise".

Letter by Jin-shan and Xue-bin Regarding Article, "Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise".

Journal: Circulation
Published: February 15, 2018
Showing 1-12 of 26

Last Updated: 09/26/2026